📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: R3 Vascular

1.1 - Company Overview

R3 Vascular Logo

R3 Vascular

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of medical devices for peripheral artery disease, including the MAGNITUDE Bioresorbable Sirolimus-Eluting Scaffold (BRS), which maintains vessel support, delivers sirolimus to prevent restenosis, and gradually resorbs into tissue.

Products and services

  • MAGNITUDE® Bioresorbable Sirolimus-Eluting Scaffold (BRS): Engineered to treat peripheral artery disease by supporting vessels while gradually absorbing into tissue and delivering sirolimus to prevent restenosis, bioresorbable

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to R3 Vascular

Embo Medical Logo

Embo Medical

HQ: Ireland Website
  • Description: Provider of innovative medical device technology to treat diseased peripheral vessels and organs, developing the first true one-shot (one device per vessel) vascular embolisation device for the peripheral vascular embolization market, where about 180,000 procedures are performed annually worldwide. Based at the National University of Ireland.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Embo Medical company profile →
Rapidscan Pharma Logo

Rapidscan Pharma

HQ: United States Website
  • Description: Provider of regadenoson, a pharmacological stress agent used in the diagnosis and risk stratification of cardiovascular disease, with licensed rights to sell in Europe and select territories.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Rapidscan Pharma company profile →
Spectranetics Logo

Spectranetics

HQ: United States Website
  • Description: Provider of excimer laser technology for minimally invasive cardiovascular procedures, marketing the only Excimer Laser System and offering a digital Instructions for Use Library with product manuals and usage guidance.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Spectranetics company profile →
Prevencio Logo

Prevencio

HQ: United States Website
  • Description: Provider of multi-proteomic cardiovascular blood tests: HART CVE uses a machine learning algorithm to predict 1-year risk of heart attack, stroke, or cardiac death; HART CADhs detects obstructive coronary artery disease; HART PAD diagnoses obstructive peripheral artery disease; HART AS diagnoses and monitors aortic valve stenosis (98% exclusion accuracy); HART Amputation Risk assesses amputation risk (87% accuracy).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Prevencio company profile →
Omeicos Logo

Omeicos

HQ: Germany Website
  • Description: Provider of first-in-class small-molecule therapeutics based on omega-3 fatty acid metabolites for the treatment and prevention of atrial fibrillation and broader indications. Offers OMT-28, a synthetic analog of 17,18-EEQ for cardiovascular inflammation and mitochondrial dysfunction; conducts the PMD-OPTION study in Primary Mitochondrial Disease; and develops a pipeline of proprietary omega-3 analogs for cardiovascular, inflammatory, and mitochondrial diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Omeicos company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for R3 Vascular

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to R3 Vascular

2.2 - Growth funds investing in similar companies to R3 Vascular

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for R3 Vascular

4.2 - Public trading comparable groups for R3 Vascular

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to R3 Vascular

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About R3 Vascular

What does R3 Vascular do?

R3 Vascular is a provider of medical devices for peripheral artery disease, including the MAGNITUDE Bioresorbable Sirolimus-Eluting Scaffold (BRS), which maintains vessel support, delivers sirolimus to prevent restenosis, and gradually resorbs into tissue.

Who are R3 Vascular's competitors?

R3 Vascular's competitors and similar companies include Embo Medical, Rapidscan Pharma, Spectranetics, Prevencio, and Omeicos.

Where is R3 Vascular headquartered?

R3 Vascular is headquartered in United States.

How many employees does R3 Vascular have?

R3 Vascular has 1,000 employees 🔒.

When was R3 Vascular founded?

R3 Vascular was founded in 2010 🔒.

What sector and industry vertical is R3 Vascular in?

R3 Vascular is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for R3 Vascular

Who are the top strategic acquirers in R3 Vascular's sector and industry

Top strategic M&A buyers and acquirers in R3 Vascular's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for R3 Vascular?

Top strategic M&A buyers groups and sectors for R3 Vascular include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in R3 Vascular's sector and industry vertical

Which are the top PE firms investing in R3 Vascular's sector and industry vertical?

Top PE firms investing in R3 Vascular's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in R3 Vascular's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in R3 Vascular's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in R3 Vascular's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to R3 Vascular include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in R3 Vascular's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for R3 Vascular?

The key public trading comparables and valuation benchmarks for R3 Vascular include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for R3 Vascular for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for R3 Vascular with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in R3 Vascular's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for R3 Vascular with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in R3 Vascular's' sector and industry vertical?

Access recent funding rounds and capital raises in R3 Vascular's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for R3 Vascular